Dr. Ong Choon Kiat

 School of Life and Physical Sciences

Principal Investigator, National Cancer Centre, Singapore


Dr. Ong Choon Kiat is the Principal Investigator of Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore (NCCS). Concurrently, he holds an appointment as a Senior Research Scientist at the Genome Institute of Singapore, and as an Assistant Professor at the Duke-NUS Medical School. Dr. Ong obtained his BSc (Hons) in 2000, and PhD in 2006 from the National University of Singapore. During his post-doctoral training, Dr. Ong has led the genomic research in various cancers prevalent in Asia including lymphoma, cholangiocarcinoma and fibroepithelial tumors of the breast.


Since 2015, Dr. Ong has focused his research on addressing challenges in treating lymphoma and has been leading the molecular study of this complex disease at the NCCS. His research interest is to improve the clinical outcomes of lymphomas’ patients through the understanding of cancer genomics and translating the findings into clinical applications. His efforts have resulted in several patents of which one has been licensed to Lucence Diagnostic for clinical assay development. Dr. Ong has published more than 60 international peer-reviewed articles in high-impact journals such as Nature, Nature Genetics, Lancet Oncology, Cancer Discovery, Blood, and Leukemia. He also served as a reviewer for more than 10 journals.


Dr. Ong represents Singapore, in leading the whole genome sequencing of T and NK-cell lymphoma in the International Cancer Genomic Consortium (ICGC). Along with other collaborating scientists in the field of cancer research, Dr. Ong was awarded the “AACR Team Science Award 2018” by the American Association for Cancer Research (AACR), which recognised the outstanding interdisciplinary team’s work in furthering the knowledge of Asian prevalent cancers, and simultaneously contributing to the progress of cancer detection, treatment and prevention.